Yüklüyor......
CD137, an attractive candidate for the immunotherapy of lung cancer
Immunotherapy has become a hotspot in cancer therapy in recent years. Several immune checkpoints inhibitors have been used to treat lung cancer. CD137 is a kind of costimulatory molecule that mediates T cell activation, which regulates the activity of immune cells in a variety of physiological and p...
Kaydedildi:
| Yayımlandı: | Cancer Sci |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7226203/ https://ncbi.nlm.nih.gov/pubmed/32073704 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14354 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|